Climate

We have initiated an analysis of the climate footprint of selected hospital medicines, from raw material to treatment. We will use this analysis to develop new tender criteria.

Furthermore, we will develop better climate calculations for hospital medicines and hearing aids for regional work on climate accounts and their climate management models. We will do this using the same method as the regions. 

Amgros will continue to roll-out the joint Nordic criteria for more sustainable packaging of all medicinal products.

In parallel, we will work on other initiatives to help reduce the climate footprint of medicinal products. In this context, we will look at the physical package inserts, since they have a climate footprint from the paper, the higher weight to transport, and waste from discarding medicines when the information in the insert has to be updated.

We will do this by continuing our dialogue with the Danish Medicines Agency in 2023 to replace the physical package inserts with electronic information. In 2023, we will continue our dialogue with the Nordic Pharmaceuticals Forum to make this a joint effort in all the Nordic countries.

In future, we will continue our close collaboration with hospital pharmacies on more energy-efficient production of the SAD medicines produced by the hospital pharmacies and for which Amgros owns marketing authorisations.

In order to achieve this goal, we will work with players in our supply chain that can effectively reduce climate impacts throughout the lifecycle of medicines. Both inside and outside Danish borders.